Business
Press Release Jun 07 2023
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated Jun 07, 2023, titled "Zydus receives final approval from the USFDA for Tadalafil Tablets USP, 20 mg".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange regarding a press release dated Jun 07, 2023, titled \"Zydus receives final approval from the USFDA for Tadalafil Tablets USP, 20 mg\". View Attachment","length":340,"tagName":"div"}]